Month: November 2020

VANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) — Fosterville South Exploration Ltd. (TSX-V:FSX) is pleased to announce today that, due to strong demand, Leviathan Gold Finance Ltd. (the “Company”) has agreed with Clarus Securities Inc. (“Clarus” or the “Agent”) to further increase the size of its previously announced C$9,990,000 private placement offering. Pursuant to the upsized deal terms, Clarus has agreed to sell up to 25,980,000 subscription receipts (the “Subscription Receipts”) of the Company at a price of $0.50 per Subscription Receipt to raise gross proceeds of up to $12,990,000.The net proceeds of the Offering will be used by the Company to fund the purchase price for the Avoca and Timor projects and for general working capital.The securities being offered have not, nor will they be registered under the United...

LONDON and CARLSBAD, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that the Company will present at the Evercore ISI HealthCONx Conference on Wednesday, December 2, 2020 at 1:50 pm EST.A live audio webcast of the presentation will be available through GW’s corporate website at www.gwpharm.com in the Investors section under Events & Presentations. A replay will be available soon after the live presentation.About GW Pharmaceuticals plc and Greenwich Biosciences, Inc.Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad...

RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2020 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) today announced Michael Kaseta has been appointed Chief Financial Officer (CFO), effective immediately. He succeeds Steve Bariahtaris who has served as Liquidia’s interim CFO since August 2020. Mr. Bariahtaris has agreed to provide assistance to the Company for a short period of time to support a smooth transition.“After an extensive search and thorough review of many outstanding candidates, it is with great pleasure that, today, we welcome Mike Kaseta to the Liquidia team,” said Neal Fowler, Chief Executive Officer at Liquidia. “I am confident that Mike’s financial expertise, business acumen, relevant therapeutic knowledge, as well as his extensive leadership across companies at varying stages in their lifecycle, make him a well-suited...

JOHNS CREEK, Ga., Nov. 30, 2020 (GLOBE NEWSWIRE) — Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries today announced a strategic agreement with Data Glove Technologies, a New Jersey based firm specializing in Infrastructure, Managed Services and Cloud Services. The agreement entails various facets including outsourcing of certain back office functions and strategic joint ventures (JV) to provide cloud and infrastructure support services to the Insurance, Banking and Healthcare marketplace.The Companies announced the setting up of two joint ventures in the US and India to target the cloud and infrastructure support areas in the BFSI industry in both geographies. The JV in the US will target the US and Candian...

The Management Board of Arco Vara AS dismissed Ivaylo Mishev from the position of manager Arco Vara Group’s Bulgarian entities (Arco Vara Bulgaria EOOD, Iztok Parkside EOOD, Arco Invest EOOD, Arco Lozen EOOD, Arco Manastirski EOOD) and elected as new manager Kaloyan Radosslavov. The Management Agreement with the new manager has been concluded for 3 years.Kaloyan Radosslavov joined the team of Arco Vara in 2018 and in a short period of time successfully turned around the Madrid project into a profitable enterprise for the group. The main responsibilities before the new manager will be to complete all ongoing projects in Bulgaria, initiate new developments, diversify the real estate portfolio and increase the overall profitability of the Bulgarian arm of the group.Prior to joining Arco Vara, Kaloyan worked as a lawyer in New York, USA....

Arco Vara AS-i juhatus vabastas Ivaylo Mishevi Arco Vara grupi Bulgaaria üksuste (Arco Vara Bulgaria EOOD, Iztok Parkside EOOD, Arco Invest EOOD, Arco Lozen EOOD, Arco Manastirski EOOD) juhataja ametikohalt ning valis uueks juhatajaks Kaloyan Radosslavovi. Juhtimise leping sõlmiti uue juhatajaga 3 aastaks.Kaloyan Radosslavov liitus Arco Vara meeskonnaga 2018. aastal ning on edukalt lühikese ajaga muutnud Madridi projekti grupi tulutoovaks ettevõtmiseks. Uue juhataja peamised ülesanded on kõigi poolikute projektide lõpetamine Bulgaarias, uute arenduste algatamine, kinnisvaraportfelli mitmekesistamine ning grupi Bulgaaria haru üldise kasumlikkuse suurendamine.Enne Arco Varaga liitumist töötas Kaloyan New Yorgis, USA-s advokaadina. Ta lõpetas Fordhami ülikooli New Yorgis, USA-s, saades õigusteaduste doktorikraadi (JD) ja ärijuhtimise magistrikraadi...

Good performance from projects and operationsIain Ross, CEO, Golar LNG, said:“Golar is pleased to report Q3 operating revenues of $95.2 million and adjusted EBITDA1 of $57.3 million, driven by a tenth consecutive quarter of uninterrupted commercial uptime in FLNG. Q3 TCE1 for the fleet at $39,100/day is above prior guidance of $35,000/day and driven by a higher year on year utilization of 80% for the quarter. TCE1 from the TFDE1 vessels excluding dry-dock days amounted to $43,800 for the quarter.We concluded the force majeure event with BP on the Gimi FLNG project, which resulted in an anticipated delay of 11 months to the project. All other terms of the 20 year lease and operating agreement remained unchanged. The project has ramped up manning levels to pre-lockdown numbers and remains on track to the new dates and with no material...

SAN CARLOS, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that the company plans to present at the following conferences in November:Piper Sandler 32nd Annual Virtual Healthcare Conference | December 1-3, 2020Date/Time: presentation available at http://ir.iovance.comCellular Immunotherapies for Solid Tumors Summit | December 1-3, 2020Presentation Title: Clinical Success of TIL Technology Platform in Multiple Solid TumorsDate/Time: Thursday, Dec. 3 at 2:10 pm ET at www.solid-tumors-summit.comLive and archived webcasts of investor conference presentations will be available in the Investors section of the Iovance website at http://ir.iovance.com.About Iovance Biotherapeutics, Inc.Iovance...